© 2011 Biolife LLC. All rights reserved. An ISO 13485:2003 Certified Company ► 941-360-1300 ► 800-722-7559 Toll Free ► Email US
Breakthrough Wound Care Product Used In Hospitals To Stop Bleeding Instantly Now
Available In Consumer Version At Walgreens
Ideal for people on blood thinners or those with thin skin, topical powder has been clinically tested and proven by
hospitals such as Florida Hospital Orlando
ORLANDO – June 27, 2011 – For seniors on blood thinning medications – or those with thin skin – treating a bleeding
wound can take hours or days to control. Changing bloody bandages and removing tape during this time can tear the
skin, only to cause more bleeding and start everything all over again.
To help seniors control nuisance bleeding and live life on their terms, Walgreens announced today the launch of
WoundSeal – a product that stops bleeding instantly – into its Orlando, Daytona and Jacksonville stores. Developed by
Sarasota-based Biolife, WoundSeal is a new consumer version of its clinically proven topical powder used by
physicians, nurses and occupational health specialists to stop bleeding cuts and skin tears in seconds.
“When a cut or laceration occurs,” states Louis Guzzi, M.D., a leading Orlando critical care physician, “the WoundSeal
powder forms an instant seal or scab once it is poured directly onto the bleeding wound. This scab stops the bleeding,
seals the wound, and allows the body’s own mechanism to begin healing.
“Through my own use in the hospital, I’ve seen how great it works for patients on blood thinners… so much so I gave it
to my mom to use. As a doctor and a son, WoundSeal gives me peace of mind knowing that the product stops bleeding
and seals wounds anytime, anywhere. I’m pleased it is widely available for in-home use.”
Already in 250 of its stores on Florida’s West Coast, Walgreens decided to place it into 280 more based on the
feedback of consumers who tried the product.
“Across this community, Walgreens is a trusted resource for innovative pharmacy, health and wellness solutions. This is
especially true for our senior customers,” states Marlon Hutchins, Walgreens Market Vice President. “We were quite
pleased with the reception WoundSeal received in our West Coast stores and amazed by our customer’s positive
reaction when they came back to get more. With this product expansion, we’re confident that WoundSeal adds to our
mission of helping people get well, stay well and live well.”
Jim Simpson of Port Charlotte was first introduced to the product during a doctor’s visit and was part of the test
consumer group to try the product.
“As a person who takes blood thinning medications, I found that the simplest of cuts took 3 to 4 hours to stop bleeding,”
states Simpson. “With WoundSeal, I simply pour the powder onto the wound and it stops the bleeding in seconds. We
now carry it every-place… in my pocket, in my car, in my wife’s purse, in my golf bag. For me, it’s a life changing
product. I’ll never be without it.”
Dr. Guzzi notes that the scab, or external seal, created when WoundSeal is added to a bleeding wound forms
independently of the blood clotting cascade, which is important for people on blood thinners. In addition to stopping
bleeding, the topical powder helps prevent infection by creating a microbial barrier over and around the wound surface.
For Biolife, adding the Orlando market to its consumer launch is an exciting time for the emerging company.
“After our successful West Coast launch and the many consumers who expressed their complete satisfaction with the
product,” states Sam Shake, president of Biolife, “the Walgreens/Biolife team knew we had something special that
needed to be geographically expanded to help more people deal with nuisance and prolonged bleeding incidents.”
WoundSeal is available at Walgreens for $6.99 for a pack of four applications.
* About The Florida Hospital Study
Editor’s Note: BioSeal CVC is the brand name of the powder in the medical market while WoundSeal is the brand name
for retail. While the amount of powder in each application is different, the formulation of the powder is exactly the same.
In a study published in June 2010 in the Journal of the Association for Vascular Access, nursing professionals at Florida
Hospital Orlando concluded that a new alternative hemostatic agent – BioSeal CVC™ Powder by Biolife – was the user-
preferred standard of care compared to the gauze control. As a result of this study, Florida Hospital has added BioSeal
CVC Powder to its PICC insertion protocol and extended the initial dressing change to seven days.
Conducted by the Vascular Access Services (VAS) Team of Florida Hospital in Orlando, one of the top vascular access
teams in the country, the study assessed the ability of BioSeal CVC™ Powder to achieve hemostasis for PICC line
insertions and to eliminate the 48-hour dressing change. The study was published in the June 2010 Journal of the
Association for Vascular Access (JAVA) and was one of four selected for podium presentation at the Association for
Vascular Access Annual Conference in September 2009.
“While gauze absorbs exudates from the PICC insertion, it can leave the site moist and increase risk of contamination.
These dressings require changing within 48 hours of insertion, thus increasing cost, time, and potential for catheter
dislodgement and infection” states Lauren Blough, RN, BS, CRNI, Clinical Specialist of the VAS Team at Florida
Hospital, and one of the Principal Investigators of the study.
“Through our study, we found that BioSeal was effective in keeping the PICC line access site dry and intact, controlled
bleeding and oozing and, after extended post trial use, demonstrated a significant decrease in CRBSIs.”
Media Contact:
Scott Carpenter –
Office - 813.210.0383
Email - scott@nextgreatbrand.com
Investor Contact:
Patti Norris
Office - 800-722-7559 x 142
Email - pnorris@biolife.com




